Skip to content
lifestyle.thepointnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
March 2, 2026
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
February 24, 2026
←
Previous Page
1
2